Volume 22, Issue 4 - Good Pharma

Transparency and the healthcare industry: The Sun is shining

Authors: Kim Pepitone, Alfred Weigel

Abstract

Download the full article

References

1. Jacobs A. Rebuilding an enduring trust in medicine: a global mandate: presidential address. American Heart Association Scientific Sessions 2004. Circulation 2005;111:3494–8.
2. Bosch X, Esfandiari B, McHenry L. Challenging medical ghostwriting in US courts. PLoS Med 2012;9(1):e1001163. Doi:10.1371/journal.pmed.1001163 10.1371/journal.pmed.1001163. Epub 2012 Jan 24.
3. Woolley K. Goodbye Ghostwriters! How to work ethically and efficiently with professional medical writers. Chest 2006;130:921–3.
4. Norris R, Bowman A, Fagan JM, Gallagher ER, Geraci AB, Gertel A, et al. International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writer. Curr Med Res Opin 2007;23:1837–40.
5. Graf C, Battisti W, Bridges D, Bruce-Winkler V, Conaty JM, Ellison JM, Field EA, et al. Research methods and reporting: publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 2009;339:b4330. Doi: 10.1136/bmj.b4330.
6. Mansi B, Clark J, David F, Gesell TM, Glasser S, Gonzales J, et al. Recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective. Mayo Clin Proc 2012;87:424–9.
7. ISMPP. Org [Internet]. Briarcliff Manor (NY): International Society for Medical Publication Professionals. ISMPP certification program: certified medical publication professional (CMPP) credential. 2009 [cited 2013 Aug 17] Available from: http://www.ismpp.org/
8. PhRMA.org. [Internet] Washington (DC): Pharmaceutical Researchers and Manufacturers of America. Principles for responsible data sharing. EFPIA and PhRMA release joint principles for responsible clinical trial data sharing to benefit patients. 2013 Jul 22 [cited 2013 Aug 17] Available from: http://www.phrma.org/
9. Advamed.org. [Internet]. Washington, DC: Advanced Medical Technology Association. Code of ethics on interactions with healthcare professionals 2009 [updated 2013 Jan 25; cited Aug 17] Available from: http://www.ismpp.org/
10. PhRMA.org. [Internet] Washington (DC): Pharmaceutical Researchers and Manufacturers of America. Principals on conduct of clinical trials: communication of clinical trial results. 2009 Oct 1 [updated 2013 Apr 8; cited 2013 Aug 17]. Available from: http://www.phrma.org/
11. Patient Protection and Affordable Care Act. 111 Congress HR 3590 2010:111–148. 2010. [updated 2010 Jan 5; cited 2013 Aug 17]. Available from: http://www.gpo.gov/fdsys/pkg/BILLS-111hr3590enr/pdf/BILLS-111hr3590enr.pdf
12. Lauer K, Patel M, Pepitone K. Physician Payment Sunshine Act: Potential implications for medical publication professionals. AMWA J 2012;27(1):7–9.
13. CMS.gov [Internet]. Baltimore (MD): Centers for Medicare and Medicaid Services. National physicians payment transparency program [updated 2013 May 22; cited 2013 Aug 17]. Available from: http://www.cms.gov/
14. Agrawal S, Brennan N, Budetti P. The Sunshine Act – effects on physicians. N Engl J Med 2013;368(22):2054–7.
15. ISMPP Suggested Approaches for Sunshine Act Interpretation and Implementation for Publication Support Requirements. [cited 2013 Aug 16] Available from: http://www.ismpp.org/assets/docs/Inititives/Sunshine_Act/ismpp%20task%20force%20document_final_081313.pdf
16. Parisi G. Coalition leaders highlight agency/publisher challenges to ensure accuracy and understanding of sunshine reports. 2013 Jun 19 [cited 2013 Aug 17]. In: Cohealthcom.org [Internet] New York: Coalition for Healthcare Communication [about 1 screen]. Available from: http://www.cohealthcom.org/
17. ISRreports.com. [Internet]. Cary (NC): Industry Standard Research. Sunshine Act pharma impact—changes in US physician behavior. [updated 2013 Feb 26, cited 2013 Aug 17] Available from: http://www.isrreports.com/
18. Jack A. Bring me sunshine: EU drug companies make payments to doctors public. BMJ 2013;347:f4342.
19. American Society of Clinical Oncology. American Society of Clinical Oncology policy for relationships with companies: background and rationale. J Clin Oncol 2013;31:2037–42.